Oncogenic Ras diverts a host TNF tumor suppressor activity into tumor promoter.

Developmental Cell
Julia B CorderoMarcos Vidal

Abstract

The roles of inflammatory cytokines and the immune response in cancer remain paradoxical. In the case of tumor necrosis factor (TNF), there is undisputed evidence indicating both protumor and antitumor activities. Recent work in Drosophila indicated that a TNF-dependent mechanism eliminates cells deficient for the polarity tumor suppressors dlg or scrib. In this study, however, we show that in tumors deficient for scrib that also expressed the Ras oncoprotein, the TNF signal was diverted into a protumor signal that enhanced tumor growth through larval arrest and stimulated invasive migration. In this case, TNF promoted malignancy and was detrimental to host survival. TNF was expressed at high levels by tumor-associated hemocytes recruited from the circulation. The expression of TNF by hemocytes was both necessary and sufficient to trigger TNF signaling in tumor cells. Our evidence suggests that tumors can evolve into malignancy through oncogenic Ras activation and the hijacking of TNF signaling.

References

Jul 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·P DefilippiJ Content
Jun 18, 2002·The EMBO Journal·Tatsushi IgakiMasayuki Miura
Oct 11, 2003·Science·Raymond A Pagliarini, Tian Xu
Nov 1, 2003·The EMBO Journal·Anthony M Brumby, Helena E Richardson
Jul 22, 2005·Nature Reviews. Cancer·Anthony M Brumby, Helena E Richardson
Dec 20, 2005·Current Opinion in Genetics & Development·Marcos Vidal, Ross L Cagan
Mar 17, 2007·Current Biology : CB·Eva KuruczIstván Andó
Nov 26, 2008·Oncogene·P O HumbertH E Richardson
Dec 3, 2008·Disease Models & Mechanisms·José Carlos Pastor-ParejaTian Xu
Apr 4, 2009·Nature Reviews. Cancer·Frances Balkwill
May 12, 2009·Immunology Letters·K S Siveen, Girija Kuttan

❮ Previous
Next ❯

Citations

Jan 18, 2011·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Sergio Casas-TintoEduardo Moreno
Oct 29, 2013·Cell Death and Differentiation·X MaT Xu
Jul 21, 2011·Nature Immunology·Yinon Ben-Neriah, Michael Karin
Nov 9, 2011·Proceedings of the National Academy of Sciences of the United States of America·Hiroshi KandaMasayuki Miura
Dec 23, 2011·Proceedings of the National Academy of Sciences of the United States of America·Chiao-Lin ChenGeorg Halder
Sep 26, 2013·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Ian G Macara, Luke McCaffrey
Oct 8, 2011·Disease Models & Mechanisms·Wayne O MilesJames A Walker
Sep 22, 2012·Disease Models & Mechanisms·Lee F WilloughbyAnthony M Brumby
May 25, 2013·Journal of Cell Science·Kate ComberMaria D Martín-Bermudo
Dec 15, 2010·Future Oncology·Fran Balkwill, Christian Joffroy
Apr 9, 2015·Developmental Cell·Alejandra Figueroa-Clarevega, David Bilder
Sep 4, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Hong XiaoWenjie Zheng
Apr 2, 2014·Seminars in Cell & Developmental Biology·Parthive H Patel, Bruce A Edgar
May 21, 2014·The Journal of Experimental Medicine·Andrew VolkJiwang Zhang
Jul 2, 2014·Seminars in Immunology·Tatsushi Igaki, Masayuki Miura
Feb 26, 2013·Leukemia & Lymphoma·Fotis AsimakopoulosPeiman Hematti
Jan 17, 2016·Developmental Biology·Hannah W R YasinRuth I Johnson
Mar 20, 2013·The Journal of Cell Biology·Romain Levayer, Eduardo Moreno
Jan 6, 2016·Immunology Letters·Leena-Maija Vanha-AhoMika Rämet
Jul 27, 2015·Current Opinion in Cell Biology·Aparna RatheeshDaria E Siekhaus
Dec 12, 2012·Trends in Cell Biology·Laura WagstaffEugenia Piddini
Oct 23, 2012·Cancer Letters·Wen-Ming Chu
Sep 21, 2013·Drug Discovery Today. Technologies·Tirtha K Das, Ross L Cagan
Jul 17, 2012·Trends in Pharmacological Sciences·Hiroaki Sakurai
Jan 3, 2012·Seminars in Cancer Biology·Melvyn T ChowMark J Smyth
Jan 3, 2012·Seminars in Cancer Biology·Frances R Balkwill, Alberto Mantovani
Nov 1, 2011·Journal of Genetics and Genomics = Yi Chuan Xue Bao·Rhoda K A Stefanatos, Marcos Vidal
Dec 23, 2015·Nature Communications·Zongzhao ZhaiBruno Lemaitre
Nov 1, 2011·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Vivek A RudrapatnaTirtha K Das
Mar 23, 2012·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Simon de BecoLaura A Johnston
Feb 6, 2013·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Fidel-Nicolás LoloEduardo Moreno
Sep 2, 2014·Wiley Interdisciplinary Reviews. Developmental Biology·Alfredo I Penzo-Méndez, Ben Z Stanger
Aug 21, 2015·Nature Reviews. Cancer·Yi Feng, Paul Martin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.